Centerstone Investors LLC reduced its holdings in Envista Holdings Co. (NYSE:NVST – Free Report) by 13.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 79,089 shares of the company’s stock after selling 12,665 shares during the period. Envista makes up about 1.4% of Centerstone Investors LLC’s investment portfolio, making the stock its 22nd biggest position. Centerstone Investors LLC’s holdings in Envista were worth $1,563,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of NVST. GAMMA Investing LLC lifted its stake in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after purchasing an additional 728 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Envista by 2.3% in the second quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock valued at $599,000 after buying an additional 800 shares during the period. Blue Trust Inc. boosted its holdings in Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after buying an additional 804 shares during the last quarter. Finally, Huntington National Bank boosted its stake in Envista by 97.8% during the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after acquiring an additional 949 shares during the last quarter.
Envista Price Performance
Shares of NVST traded up $0.10 during trading hours on Thursday, hitting $20.62. 118,435 shares of the company were exchanged, compared to its average volume of 2,363,972. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $25.64. The firm’s fifty day moving average is $20.03 and its 200 day moving average is $18.41. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The company has a market cap of $3.55 billion, a price-to-earnings ratio of -2.64, a P/E/G ratio of 2.77 and a beta of 1.31.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on the company. Stifel Nicolaus upped their price objective on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Mizuho started coverage on shares of Envista in a research note on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price target for the company. Piper Sandler lifted their price objective on shares of Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and increased their target price for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Finally, Robert W. Baird lifted their price target on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $20.65.
Read Our Latest Analysis on NVST
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- Quiet Period Expirations Explained
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
- How to Use the MarketBeat Excel Dividend Calculator
- Intel Stock: A Value Play in the Quantum Computing Space
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.